- Home
- VIVS vs ISPC Comparison
VIVS vs ISPC Comparison
Compare VIVS & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVS
- ISPC
- Stock Information
- Founded
- VIVS 2007
- ISPC 2009
- Country
- VIVS United States
- ISPC United States
- Employees
- VIVS N/A
- ISPC N/A
- Industry
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- ISPC Precision Instruments
- Sector
- VIVS Health Care
- ISPC Health Care
- Exchange
- VIVS Nasdaq
- ISPC Nasdaq
- Market Cap
- VIVS 8.1M
- ISPC 6.9M
- IPO Year
- VIVS N/A
- ISPC 2021
- Fundamental
- Price
- VIVS $2.28
- ISPC $0.86
- Analyst Decision
- VIVS
- ISPC
- Analyst Count
- VIVS 0
- ISPC 0
- Target Price
- VIVS N/A
- ISPC N/A
- AVG Volume (30 Days)
- VIVS 104.1K
- ISPC 594.2K
- Earning Date
- VIVS 11-12-2025
- ISPC 11-14-2025
- Dividend Yield
- VIVS N/A
- ISPC N/A
- EPS Growth
- VIVS N/A
- ISPC N/A
- EPS
- VIVS N/A
- ISPC N/A
- Revenue
- VIVS $142,000.00
- ISPC $5,908,088.00
- Revenue This Year
- VIVS $42.38
- ISPC $35.93
- Revenue Next Year
- VIVS $15.42
- ISPC N/A
- P/E Ratio
- VIVS N/A
- ISPC N/A
- Revenue Growth
- VIVS 94.52
- ISPC N/A
- 52 Week Low
- VIVS $1.41
- ISPC $0.64
- 52 Week High
- VIVS $21.96
- ISPC $5.48
- Technical
- Relative Strength Index (RSI)
- VIVS 38.84
- ISPC 44.70
- Support Level
- VIVS $2.14
- ISPC $0.72
- Resistance Level
- VIVS $2.44
- ISPC $0.91
- Average True Range (ATR)
- VIVS 0.27
- ISPC 0.08
- MACD
- VIVS -0.09
- ISPC 0.00
- Stochastic Oscillator
- VIVS 10.00
- ISPC 49.46
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.